Opdivo Offers Some Hope for a Deadly Lung Cancer

The cancer drug Opdivo (nivolumab) may offer hope of a longer life for some patients with advanced lung cancer. Currently, only about 5 percent of patients with advanced non-small-cell lung cancer survive five years or more. But that rate rose to about 16 percent among a group taking Opdivo. Opdivo is an immunotherapy drug, which [...]

May 17th, 2017|News|

Zika-Infected American Women Had Babies With Birth Defects

About 10% of pregnant American women who contracted the Zika virus had children or fetuses with birth defects, according to the Centers for Disease Control (CDC). The latest CDC analysis spans the 50 states and the District of Columbia; nationwide, 1,297 pregnant women with laboratory evidence of potential Zika infection across 44 states were reported [...]

May 9th, 2017|News|

Vincent Huart – welcome to our newest team member

IDR Medical is delighted to welcome its latest addition to the consulting team, Vincent Huart.  Vincent is a recent pharmacology master’s graduate from the university of Glasgow. He has had first-hand industrial experience working as an In Vitro Pharmacologist at Redx Oncology. While on his work placement Vincent worked as part of a research team specializing in [...]

March 1st, 2016|News|